Form 4 Filing for Axogen, Inc. - Insider Transaction

John Johnson, a director at Axogen, Inc., acquired 14,150 shares of common stock through the vesting of restricted stock units on June 19, 2026. This transaction, valued at $0, represents an annual equity grant for his service as a director. The grant, based on a $150,000 valuation as of the grant date, vests on the one-year anniversary of the grant date. Each restricted stock unit corresponds to one share of Axogen, Inc. common stock. Following this transaction, Johnson holds 14,150 shares of common stock directly.